-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Foghorn Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
- Foghorn Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$23M, a 22.1% increase year-over-year.
- Foghorn Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$86.4M, a 24.6% increase year-over-year.
- Foghorn Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$98.4M, a 9.6% increase from 2022.
- Foghorn Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$109M, a 7.46% decline from 2021.
- Foghorn Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$101M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)